| 1 | The 2021 WHO Classification of Tumors of the Central Nervous System: a summary | Neuro-Oncology | 2021 | 6,209 |
| 2 | Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities | Cell | 2017 | 3,073 |
| 3 | DNA methylation-based classification of central nervous system tumours | Nature | 2018 | 2,005 |
| 4 | The Human Cell Atlas | ELife | 0 | 1,396 |
| 5 | The landscape of genomic alterations across childhood cancers | Nature | 2018 | 1,074 |
| 6 | Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers | Nature Medicine | 2020 | 866 |
| 7 | A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal | Modern Pathology | 2018 | 791 |
| 8 | Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids | Cell | 2018 | 734 |
| 9 | Mutational signature in colorectal cancer caused by genotoxic pks+ E. coli | Nature | 2020 | 678 |
| 10 | Long‐term expanding human airway organoids for disease modeling | EMBO Journal | 2019 | 645 |
| 11 | Disease Modeling in Stem Cell-Derived 3D Organoid Systems | Trends in Molecular Medicine | 2017 | 603 |
| 12 | WHO 2016 Classification of gliomas | Neuropathology and Applied Neurobiology | 2018 | 592 |
| 13 | Long-Term Expansion of Functional Mouse and Human Hepatocytes as 3D Organoids | Cell | 2018 | 554 |
| 14 | An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity | Nature Medicine | 2019 | 532 |
| 15 | Interrogating open issues in cancer precision medicine with patient-derived xenografts | Nature Reviews Cancer | 2017 | 518 |
| 16 | A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening | Cell Stem Cell | 2018 | 498 |
| 17 | cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading | Brain Pathology | 2020 | 394 |
| 18 | Longitudinal molecular trajectories of diffuse glioma in adults | Nature | 2019 | 350 |
| 19 | Neuroblastoma is composed of two super-enhancer-associated differentiation states | Nature Genetics | 2017 | 344 |
| 20 | Extracellular matrix hydrogel derived from decellularized tissues enables endodermal organoid culture | Nature Communications | 2019 | 339 |
| 21 | Human Organoids: Tools for Understanding Biology and Treating Diseases | Annual Review of Pathology: Mechanisms of Disease | 2020 | 320 |
| 22 | Sarcoma classification by DNA methylation profiling | Nature Communications | 2021 | 316 |
| 23 | EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours | Annals of Oncology | 2021 | 315 |
| 24 | TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors | Nature Genetics | 2015 | 309 |
| 25 | Tubuloids derived from human adult kidney and urine for personalized disease modeling | Nature Biotechnology | 2019 | 301 |
| 26 | cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant | Acta Neuropathologica | 2018 | 294 |
| 27 | Xenograft and organoid model systems in cancer research | EMBO Journal | 2019 | 285 |
| 28 | Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP–RTSG 2016 protocol | Nature Reviews Urology | 2017 | 281 |
| 29 | Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up | Annals of Oncology | 2020 | 270 |
| 30 | MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy | Cancers | 2020 | 259 |
| 31 | Sleep characteristics across the lifespan in 1.1 million people from the Netherlands, United Kingdom and United States: a systematic review and meta-analysis | Nature Human Behaviour | 2020 | 257 |
| 32 | Fasting-mimicking diet and hormone therapy induce breast cancer regression | Nature | 2020 | 243 |
| 33 | In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels | Nature Biotechnology | 2021 | 243 |
| 34 | Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III Study | Journal of Clinical Oncology | 2021 | 226 |
| 35 | Organoids in immunological research | Nature Reviews Immunology | 2019 | 224 |
| 36 | Glioma: experimental models and reality | Acta Neuropathologica | 2017 | 214 |
| 37 | Differentiated human airway organoids to assess infectivity of emerging influenza virus | Proceedings of the National Academy of Sciences of the United States of America | 2018 | 214 |
| 38 | Glioma progression is shaped by genetic evolution and microenvironment interactions | Cell | 2022 | 211 |
| 39 | Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study | Journal of Clinical Oncology | 2019 | 209 |
| 40 | Human germ cell tumours from a developmental perspective | Nature Reviews Cancer | 2019 | 203 |
| 41 | Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study | Lancet Oncology, The | 2021 | 202 |
| 42 | An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity | Nature Communications | 2020 | 195 |
| 43 | Chemotherapy Side-Effects: Not All DNA Damage Is Equal | Cancers | 2022 | 193 |
| 44 | Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas | Endocrine Pathology | 2022 | 192 |
| 45 | The mutational landscape of human somatic and germline cells | Nature | 2021 | 185 |
| 46 | Retinoblastoma and Neuroblastoma Predisposition and Surveillance | Clinical Cancer Research | 2017 | 184 |
| 47 | Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial | Lancet Oncology, The | 2019 | 177 |
| 48 | Building consensus on definition and nomenclature of hepatic, pancreatic, and biliary organoids | Cell Stem Cell | 2021 | 176 |
| 49 | Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation | Haematologica | 2016 | 172 |
| 50 | Healthy play, better coping: The importance of play for the development of children in health and disease | Neuroscience and Biobehavioral Reviews | 2018 | 170 |
